CRISPR-CAS9 GENE EDITING IN PHARMACEUTICAL DEVELOPMENT FOR PRECISION MEDICINE

Authors

  • Mrs. M Sravani Trinity College of Pharmaceutical Sciences Author
  • Dr. D. Prabhakar Trinity College of Pharmaceutical Sciences Author

Keywords:

CRISPR-Cas9, Gene Editing, Precision Medicine, Pharmaceutical Development, Personalized Therapy, Genetic Disorders, Drug Discovery, Genome Engineering, Targeted Treatment, Biotechnology

Abstract

This research primarily examines the application of CRISPR-Cas9 gene editing technology in the development of precision medicine, emphasizing its potential to revolutionize the treatment of genetic illnesses. CRISPR-Cas9 enables the exact alteration of DNA sequences, allowing researchers to identify, modify, and rectify genes responsible for diseases, hence accelerating the creation of therapeutics. The application of this technology in precision medicine facilitates the development of pharmaceuticals customized to each patient's genetic profile. This enhances therapeutic outcomes and reduces adverse effects. In addition to addressing side effects, ethical dilemmas, and regulatory frameworks, recent advancements underscore the significance of developing novel therapies for cancer, infectious diseases, and uncommon genetic disorders. Ultimately, CRISPR-Cas9 is a transformative instrument that is altering contemporary pharmaceutical research, enabling the development of more targeted, efficient, and personalized therapies.

Author Biographies

  • Mrs. M Sravani, Trinity College of Pharmaceutical Sciences

    Associate Professor, Trinity College of Pharmaceutical Sciences, Peddapalli, Telangana

  • Dr. D. Prabhakar, Trinity College of Pharmaceutical Sciences

    Professor & Principal, Department of M.Pharmacy – Pharmaceutics, Trinity College of Pharmaceutical Sciences, Peddapalli, Telangana

Downloads

Published

2026-04-15

Issue

Vol. 1 No. 1 (2026): Volume 1, Issue 1 (January-June, 2026)

Section

Articles